FrancophonIA/ELRC3.0 huggingface dataset:
English: Dose adjustments of other medicinal products used in combination with cannabidiol A physician experienced in treating patients who are on concomitant antiepileptic drugs (AEDs) should evaluate the need for dose adjustments of cannabidiol or of the concomitant medicinal product(s) to manage potential drug interactions (see sections 4.4 and 4.5).
Croatian: Prilagodbe doza drugih lijekova koji se primjenjuju u kombinaciji s kanabidiolom Liječnik iskusan u liječenju bolesnika koji istovremeno uzimaju antiepileptike mora procijeniti potrebu za prilagodbom doze kanabidiola ili istovremeno primjenjivanog lijeka(lijekova) kako bi pazio na potencijalne interakcije lijekova (vidjeti dijelove 4.4 i 4.5).
English: There are no human studies on excretion of cannabidiol in breast milk.
Croatian: Nema ispitivanja na ljudima glede izlučivanja kanabidiola u mlijeko.
English: The phase I metabolites identified in standard in vitro assays were 7-COOH-CBD, 7-OH-CBD, and 6-OH-CBD (a minor circulating metabolite).
Croatian: Metaboliti faze I identificirani u standardnim in vitro testovima su bili 7-COOH-CBD, 7-OH-CBD i 6-OH-CBD (slabije zastupljen cirkulirajući metabolit).
English: The lowest dose causing developmental toxicity in juvenile rats (15 mg/kg subcutaneous/100 mg/kg oral) was associated with Cmax cannabidiol exposures approximately 20 times that in paediatric subjects at 20 mg/kg/day.
Croatian: Najmanja doza koja je uzrokovala razvojnu toksičnost u mladih štakora (15 mg/kg supkutano/ 100 mg/kg peroralno) je povezana s Cmax izloženostima kanabidiolu oko 20 većima od one u pedijatrijskih ispitanika pri dozi od 20 mg/kg/dan.
English: midazolam, phenytoin, stiripentol and valproate that are used to treat seizures - medicines used to treat acid reflux (heartburn or acid regurgitation) such as omeprazole - mitotane (a medicine used to treat tumours in the adrenal gland) - morphine or diflunisal (medicines used to treat pain) - efavirenz (a medicine used to treat HIV/AIDS) - theophylline (a medicine used to treat asthma) - caffeine (a medicine for babies who need help breathing) - propofol (an anaesthetic used for people undergoing surgery) - simvastatin, fenofibrate, gemfibrozil, (medicines used to reduce cholesterol/lipids) - enzalutamide (a medicine to treat prostate cancer) - bupropion (a medicine to help stop smoking or for treating obesity) - St. John's wort (Hypericum perforatum) (a herbal medicine used to treat mild anxiety) - medicines to treat bacterial infections, such as rifampin, clarithromycin and erythromycin
Croatian: lorazepama, midazolama, fenitoina, stiripentola i valproata - lijekovi za liječenje kiselinskog refluksa (žgaravica ili vraćanje kiseline), poput omeprazola - mitotan (lijek za liječenje tumora nadbubrežne žlijezde) - morfin ili diflunisal (lijekovi protiv bolova) - efavirenz (lijek kojim se liječi HIV/AIDS) - teofilin (lijek kojim se liječi astma) - kofein (lijek za bebe kojima treba pomoć za disanje) - propofol (anestetik za osobe koje idu na operaciju) - simvastatin, fenofibrat, gemfibrozil, (lijekovi za smanjenje kolesterola/lipida) - enzalutamid (lijek za liječenje raka prostate) - bupropion (lijek za pomoć u prestanku pušenja ili za liječenje pretilosti) - gospina trava (Hypericum perforatum) (biljni lijek za liječenje blaže tjeskobe) - lijekovi za liječenje bakterijskih infekcija, poput rifampina, klaritromicina i eritromicina
English: Cannabidiol is extensively metabolised by the liver via CYP450 enzymes and the UGT enzymes.
Croatian: Kanabidiol se ekstenzivno metabolizira u jetri putem enzima CYP450 i UGT.
English: Based on individual clinical response and tolerability, each dose can be further increased in weekly increments of 2.5 mg/kg administered twice daily (5 mg/kg/day) up to a maximum recommended dose of 10 mg/kg twice daily (20 mg/kg/day).
Croatian: Na temelju individualnog kliničkog odgovora i podnošljivosti, svaka se doza može dodatno povećati u tjednim koracima od 2,5 mg/kg dvaput dnevno (5 mg/kg/dan) do najviše preporučene doze od 10 mg/kg dvaput dnevno (20 mg/kg/dan).
English: Strawberry flavour (including benzyl alcohol)
Croatian: Okus jagode (uključujući benzilni alkohol)
English: If a patient develops clinical signs or symptoms suggestive of hepatic dysfunction, serum transaminases and total bilirubin should be promptly measured and treatment with cannabidiol should be interrupted or discontinued, as appropriate.
Croatian: Ako bolesnik razvije kliničke znakove ili simptome koji sugeriraju disfunkciju jetre, treba hitno izmjeriti serumske transaminaze i ukupni bilirubin, a liječenje kanabidiolom treba privremeno ili trajno prekinuti, kako je primjereno.
English: The key secondary endpoint for GWPCARE1 was the proportion of patients with at least a 50% reduction in convulsive seizure frequency.
Croatian: Ključna sekundarna mjera ishoda za GWPCARE1 je bio udio bolesnika sa smanjenjem učestalosti konvulzivnih napadaja od najmanje 50%.
English: The most frequent cause of discontinuations was transaminase elevation.
Croatian: Najčešći uzrok prekida uzimanja lijeka bilo je povišenje transaminaza.
English: Lamotrigine
Croatian: Lamotrigin
English: No formal drug-drug interaction studies have been conducted with cannabidiol in combination with UGT inhibitors, therefore caution should be taken when co-administering drugs that are known inhibitors of these UGTs.
Croatian: Nisu provedena formalna ispitivanja interakcija među lijekovima za kanabidiol u kombinaciji s inhibitorima UGT-a, pa je potreban oprez kod istovremene primjene lijekova za koje se zna da inhibiraju UGT-ove.
English: Elderly patients Pharmacokinetics of cannabidiol have not been studied in patients > 55 years of age.
Croatian: Stariji bolesnici Farmakokinetika kanabidiola nije proučavana u bolesnika starijih od 55 godina.
English: GW Pharma (International) B.V., Databankweg 26, 3821AL Amersfoort, The Netherlands e-mail: info@gwpharm.com
Croatian: GW Pharma (International) B.V., Databankweg 26, 3821AL Amersfoort, Nizozemska e-pošta: info@gwpharm.com
English: Co-administration of cannabidiol is also predicted to cause clinically significant interactions with CYP2C8 (repaglinide) and CYP2C9 (e.g., warfarin) substrates.
Croatian: Također se predviđa kako će istovremena primjena kanabidiola uzrokovati klinički značajne interakcije sa supstratima CYP2C8 (repaglinid) i CYP2C9 (npr. varfarin).
English: In some patients, a synergistic effect of concomitant treatment with valproate upon baseline elevated transaminases resulted in a higher risk of transaminase elevations.
Croatian: U nekih je bolesnika sinergijski učinak istovremenog liječenja valproatom nakon povišene početne razine transaminaza rezultirao većim rizikom za povišenje transaminaza.
English: Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system.
Croatian: Od zdravstvenih radnika se traži da prijave svaku sumnju na nuspojavu lijeka putem nacionalnog sustava prijave nuspojava: navedenog u Dodatku V.
English: Dose adjustment of any co-administered medicinal product that is known to affect the liver should be considered (e.g., valproate and clobazam) (see section 4.5).
Croatian: Treba razmotriti i prilagođavanje doze svih istovremeno primijenjenih lijekova za koje je poznato da utječu na jetru (npr. valproat i klobazam) (vidjeti dio 4.5).
English: The pharmacokinetics of cannabidiol are complex and may cause interactions with the patient's concomitant AED treatments.
Croatian: Farmakokinetika kanabidiola je složena je i može uzrokovati interakcije u bolesnika koji istovremeno uzimaju antiepileptike.
English: Skin and subcutaneous tissue disorders Common
Croatian: Poremećaji kože i potkožnog tkiva Često
English: It is not known if cannabidiol is dialysable.
Croatian: Nije poznato izlučuje li se kanabidiol dijalizom.
English: After one week, the dose should be increased to a maintenance dose of 5 mg/kg twice daily (10 mg/kg/day).
Croatian: Nakon jednog tjedna dozu treba povećati na dozu održavanja od 5 mg/kg dvaput dnevno (10 mg/kg/dan).
English: Approximately 65% of the patients were taking concomitant clobazam.
Croatian: Oko 65% bolesnika istovremeno je uzimalo klobazam.
English: In individual patients titration up to a maximum dose of 20 mg/kg/day may be considered, based on the benefit-risk (see Section 4.2).
Croatian: Kod pojedinih bolesnika može se razmotriti titracija do maksimalne doze od 20 mg/kg/dan na temelju omjera koristi i rizika (vidjeti dio 4.2).
English: No human data on the effect of cannabidiol on fertility are available.
Croatian: Nisu dostupni podaci o učinku kanabidiola na plodnost u ljudi.
English: Cannabidiol is not a substrate for or an inhibitor of the brain uptake transporters OATP1A2 and OATP2B1.
Croatian: Kanabidiol nije supstrat niti inhibitor za prijenosnike unosa u mozak OATP1A2 i OATP2B1.
English: Placebo 20 mg/kg/day Difference or Percent Reduction Compared with Placebo (95% CI), p-valueb GWPCARE2
Croatian: Placebo 20 mg/kg/dan Razlika ili postotno smanjenje u usporedbi s placebom (95% CI), p-vrijednostb GWPCARE2
English: Table 1: Dose adjustments in patients with moderate or severe hepatic impairment
Croatian: Tablica 1: Prilagodbe doza u bolesnika s umjerenim ili teškim oštećenjem funkcije jetre
English: When cannabidiol and clobazam are co-administered, bi-directional PK interactions occur.
Croatian: Kad se kanabidiol i klobazam primjenjuju zajedno, dolazi do dvosmjernih PK interakcija.
English: CYP3A4 or CYP2C19 inducers
Croatian: Induktori CYP3A4 ili CYP2C19
English: Epidyolex is indicated for use as adjunctive therapy of seizures associated with Lennox-Gastaut syndrome (LGS) or Dravet syndrome (DS), in conjunction with clobazam, for patients 2 years of age and older.
Croatian: Epidyolex je indiciran za uporabu kao dodatna terapija napadaja povezanih sa Lennox-Gastautovim sindromom (LGS) ili Dravetovim sindromom (DS) zajedno s klobazamom u bolesnika starih 2 ili više godina.
English: Reduction in dose of clobazam should be considered if somnolence or sedation are experienced when clobazam is co-administered with cannabidiol.
Croatian: Treba razmotriti smanjenje doze klobazama ako dođe do pojave somnolencije ili sedacije kad se klobazam primjenjuje zajedno s kanabidiolom.
English: The NOAEL was associated with maternal plasma exposures (AUC) approximately 50 times greater than the anticipated exposure in humans at 20 mg/kg/day.
Croatian: NOAEL je povezan s izloženostima u plazmi majke (AUC) oko 50 puta većima od očekivane izloženosti u ljudi pri 20 mg/kg/dan.
English: Weight decreased a Grouped Terms: Pneumonia: Pneumonia, Pneumonia RSV, Pneumonia mycoplasmal, Pneumonia adenoviral, Pneumonia viral, Aspiration pneumonia; Somnolence: Somnolence, Sedation.
Croatian: Smanjenje tjelesne težine a Grupni pojmovi: Upala pluća: upala pluća, upala pluća uzrokovana RSV-om, mikoplazmalna upala pluća, adenovirusna upala pluća, virusna upala pluća, aspiracijska upala pluća; Somnolencija: somnolencija, sedacija.
English: Dose reduction of the substrates may be necessary when cannabidiol is administered concomitantly with substrates of these UGTs.
Croatian: Može biti potrebno smanjenje doze supstrata ako se kanabidiol primjenjuje zajedno sa supstratima ovih UGT-ova.
English: In controlled studies for LGS and DS, the incidence of ALT elevations above 3 times the ULN was 13% in cannabidiol-treated patients compared with 1% in patients on placebo.
Croatian: U kontroliranim ispitivanjima za LGS i DS je primijećena incidencija povišenja ALT-a za više od 3 puta GGN od 13% u bolesnika liječenih kanabidiolom u odnosu na 1% u bolesnika na placebu.
English: Greater improvements in overall condition, as measured by Global Impression of Change scores at the last visit, were reported by caregivers and patients with both doses of cannabidiol (73% on
Croatian: Veća poboljšanja u ukupnom stanju, mjereno rezultatima Globalnog dojma promjene na zadnjem posjetu prijavljena su i od njegovatelja i bolesnika s obje doze kanabidiola (73% na 10 mg/kg/dan,
English: The most commonly used cAEDs (> 25% of patients) in both trials were valproate, clobazam, lamotrigine, levetiracetam, and rufinamide.
Croatian: Najčešće istovremeno primjenjivani antiepileptici (> 25% bolesnika) u oba ispitivanja su bili: valproat, klobazam, lamotrigin, levetiracetam i rufinamid.
English: In cannabidiol-treated patients, the incidence of ALT elevations greater than 3 times the ULN was 23% in patients taking both concomitant valproate and clobazam, 17% in patients taking concomitant valproate (without clobazam), 3% in patients taking concomitant clobazam (without valproate), and 2% in patients taking neither drug.
Croatian: U bolesnika liječenih kanabidiolom je incidencija povišenja ALT-a većeg od 3 puta GGN bila 23% u bolesnika koji istovremeno uzimaju valproat i klobazam, 17% u bolesnika koji istovremeno uzimaju valproat (bez klobazama), 3% u bolesnika koji istovremeno uzimaju klobazam (bez valproata), te 2% u bolesnika koji ne uzimaju nijedan od tih lijekova.
English: Epidyolex is used in combination with clobazam or with clobazam and other antiepileptic medicines to treat seizures that occur with two rare conditions, called Dravet syndrome and Lennox-Gastaut syndrome.
Croatian: Epidyolex se primjenjuje u kombinaciji s klobazamom ili klobazamom i drugim antiepilepticima za liječenje napadaja koji se pojavljuju u dvama rijetkim stanjima, Dravetovom sundromu i Lennox-Gastautovom sindromu.
English: No effects on the Cmax or AUC of cannabidiol were observed following administration of a single dose of cannabidiol 200 mg in subjects with mild, moderate, or severe renal impairment when compared to patients with normal renal function.
Croatian: Nisu uočeni učinci na Cmax ili AUC kanabidiola nakon primjene jedne doze kanabidiola od 200 mg u ispitanika s blagim, umjerenim ili teškim oštećenjem funkcije bubrega u usporedbi s bolesnicima s normalnom bubrežnom funkcijom.
English: Adverse reactions reported with cannabidiol in placebo-controlled clinical studies are listed in the table below by System Organ Class and frequency.
Croatian: Nuspojave prijavljene s kanabidiolom u kliničkim ispitivanjima kontroliranima placebom navedene su u donjoj tablici prema klasifikaciji organskih sustava i učestalosti.
English: As with other AEDs, a clinically relevant increase in seizure frequency may occur during treatment with cannabidiol, which may require adjustment in dose of cannabidiol and/or concomitant AEDs, or discontinuation of cannabidiol, should the benefit-risk be negative.
Croatian: Kao i kod drugih antiepileptika, tijekom liječenja kanabidiolom može doći do klinički relevantnog povećanja učestalosti napadaja, što može zahtijevati prilagodbu doze kanabidiola i/ili istovremeno korištenog antiepileptika, odnosno prekid primjene kanabidiola, ako bi omjer koristi i rizika bio negativan.
English: Serum transaminases and total bilirubin levels should be obtained at 1 month, 3 months, and 6 months after initiation of treatment with cannabidiol, and periodically thereafter or as clinically indicated.
Croatian: Razine serumskih transaminaza i ukupnog bilirubina treba izmjeriti 1 mjesec, 3 mjeseca i 6 mjeseci nakon početka liječenja kanabidiolom, te kasnije povremeno, odnosno kako je klinički indicirano.
English: The metabolite 7-COOH-CBD is a P-gp/MDR1 substrate and has the potential to inhibit BCRP, OATP1B3, and OAT3.
Croatian: Metabolit 7-COOH-CBD je supstrat P-glikoproteina/MDR1 i ima potencijal inhibicije BCRP, OATP1B3 i OAT3.
English: The most common adverse reactions are somnolence, decreased appetite, diarrhoea, pyrexia, fatigue, and vomiting.
Croatian: Najčešće nuspojave su somnolencija, smanjenje teka, proljev, pireksija, umor i povraćanje.
English: Cannabidiol can cause weight loss.
Croatian: Kanabidiol može uzrokovati smanjenje tjelesne težine.
English: Patients with identified baseline elevations of ALT or AST and patients who are taking valproate should have serum transaminases and total bilirubin levels obtained at 2 weeks, 1 month, 2 months, 3 months, and 6 months after initiation of treatment with cannabidiol, and periodically thereafter or as clinically indicated.
Croatian: Za bolesnike s identificiranim povišenjem početne razine ALT-a ili AST-a i bolesnike koji uzimaju valproat bi trebalo dobiti razine serumskih transaminaza i ukupnog bilirubina 2 tjedna, 1 mjesec, 2 mjeseca, 3 mjeseca i 6 mjeseci nakon početka liječenja kanabidiolom, te kasnije povremeno ili prema kliničkoj indikaciji.
English: The dose titration should be performed as detailed in the table below.
Croatian: Titraciju doze treba obaviti u skladu s podacima u tablici u nastavku.
English: Phenytoin
Croatian: Fenitoin
English: Interaction resulting in a decrease (approximately 30%) in Cmax and AUC of the active metabolite 7-OH-CBD in HV* trials.
Croatian: Interakcija koja dovodi do pada (oko 30%) Cmax i AUC aktivnog metabolita 7-OH-CBD u ispitivanjima na zdravim dobrovoljcima.
English: Cannabidiol induces CYP1A2 and CYP2B6 mRNA expression at clinically relevant concentrations.
Croatian: Kanabidiol inducira ekspresiju CYP1A2 i CYP2B6 mRNA u klinički značajnim koncentracijama.
English: Insert the tip of the correct oral syringe fully into the bottle adaptor, and with the oral syringe in place, turn the bottle upside down.
Croatian: Umetnite vrh štrcaljke za usta do kraja u adapter, pa kad štrcaljka za usta bude na svom mjestu, okrenite bočicu naopako.
English: Five percent (5%) of patients (all on valproate) taking cannabidiol 10 mg/kg/day experienced ALT elevations greater than 3 times the ULN when ALT was above the ULN at baseline, compared with 3% of patients (all on valproate) in whom ALT was within the normal range at baseline.
Croatian: Pet posto (5%) bolesnika (svi na valproatu) koji su uzimali kanabidiol u dozi od 10 mg/kg/dan je imalo povišenje razine ALT-a veće od 3 puta GGN kad je ALT bio iznad vrijednosti GGN na početku, u odnosu na 3% bolesnika (svi na valproatu) kad je ALT bio unutar normalnih granica na početku.
English: Cannabidiol should be used with caution in patients with moderate or severe hepatic impairment.
Croatian: Kanabidiol treba primjenjivati s oprezom u bolesnika s umjerenim ili teškim oštećenjem funkcije jetre.
English: Taking Epidyolex with food can increase the amount of medicine your body takes in. You should try, as far as possible, to take Epidyolex consistently either with or without food, and according to your daily routine, so you get the same effect each time.
Croatian: Trebali biste, koliko god je to moguće, uzimati Epidyolex dosljedno s hranom ili bez nje, i u skladu sa svojom dnevnom rutinom, kako biste uvijek imali isti učinak.
English: GWPCARE3 Placebo 10 mg/kg/day 20 mg/kg/day GWPCARE4 Placebo 20 mg/kg/day Difference or Percent Reduction Compared with Placebo (95% CI), p-valueb
Croatian: GWPCARE3 Placebo 10 mg/kg/dan 20 mg/kg/dan GWPCARE4 Placebo 20 mg/kg/dan Razlika ili postotno smanjenje u usporedbi s placebom (95% CI), p-vrijednostb
English: Cannabidiol and 7-OH-CBD are not substrates for or inhibitors of efflux transports P-gp/MDR1, BCRP or BSEP at clinically relevant plasma concentrations.
Croatian: Kanabidiol i 7-OH-CBD nisu supstrati niti inhibitori prijenosnika izbacivanja P-glikoproteina/MDR1, BCRP ili BSEP pri klinički značajnim koncentracijama u plazmi.
English: Because of potential for both induction and inhibition of enzyme activity, dose adjustment of substrates of CYP1A2 and CYP2B6 should be considered, as clinically appropriate.
Croatian: Zbog postojanja mogućnosti indukcije i inhibicije aktivnosti enzima treba razmotriti i prilagođavanje doze supstrata CYP1A2 i CYP2B6 prema kliničkoj situaciji.
English: The interactions are summarised in the table below.
Croatian: Interakcije su sažete u tablici u nastavku.
English: Lamotrigine is a substrate for UGT enzymes including UGT2B7 which is inhibited by cannabidiol in vitro.
Croatian: Lamotrigin je supstrat enzima UGT, uključujući UGT2B7, kojeg kanabidiol inhibira in vitro.
English: The primary endpoint was the change in convulsive seizure frequency during the treatment period (Day 1 to the end of the evaluable period) compared to baseline (GWPCARE2), and the percentage change from baseline in convulsive seizures per 28 days over the treatment period (GWPCARE1) for the cannabidiol groups compared to placebo.
Croatian: Primarna mjera ishoda bila je promjena učestalosti konvulzivnih napadaja tijekom razdoblja liječenja (Dan 1 do kraja razdoblja koje se može procijeniti) u usporedbi s početkom (GWPCARE2), te postotna promjena konvulzivnih napadaja od početka na 28 dana tijekom razdoblja liječenja (GWPCARE1) za skupine liječene kanabidiolom u usporedbi s placebom.
English: Exposure to phenytoin may be increased when it is co-administered with cannabidiol, as phenytoin is largely metabolised via CYP2C9, which is inhibited by cannabidiol in vitro.
Croatian: Izloženost fenitoinu može se povećati kad se primjenjuje zajedno s kanabidiolom jer se fenitoin značajno metabolizira putem CYP2C9, kojeg kanabidiol inhibira in vitro.
English: The NOAEL was associated with maternal plasma cannabidiol exposures approximately 9 times that in humans at 20 mg/kg/day.
Croatian: NOAEL je povezan s izloženostima kanabidiolu u plazmi majke oko 9 puta većima od one u ljudi pri 20 mg/kg/dan.
English: The embryo-foetal development (EFD) study performed in rabbits evaluated doses of 50, 80, or 125 mg/kg/day.
Croatian: Ispitivanje embriofetalnog razvoja provedeno na zečevima procjenjivalo je doze od 50, 80 ili 125 mg/kg/dan.
English: It comes in a bottle which has a child-resistant cap, together with two identical 5 ml or 1 ml oral dosing syringes and two bottle adaptors for using these syringes.
Croatian: Dolazi u bočici koja ima zatvarač siguran za djecu, zajedno s dvjema jednakim dozirnim štrcaljkama za usta od 5 ml ili 1 ml i dvama adapterima koji se upotrebljavaju s ovim štrcaljkama.
English: Paediatric patients Pharmacokinetics of cannabidiol has not been studied in paediatric patients < 2 years of age.
Croatian: Pedijatrijski bolesnici Farmakokinetika kanabidiola nije proučavana u pedijatrijskih bolesnika mlađih od 2 godine.
English: A lower starting dose is recommended in patients with moderate or severe hepatic impairment.
Croatian: Niža početna doza se preporuča bolesnicima s umjerenim ili teškim oštećenjem funkcije jetre.
English: In LGS and DS patients, the mean decrease in haemoglobin from baseline to end of treatment was −0.37 g/dL in cannabidiol-treated patients.
Croatian: U bolesnika koji imaju LGS i DS, srednja vrijednost smanjenja hemoglobina od početka do završetka liječenja je bila −0,37 g/dl u bolesnika koji su uzimali kanabidiol.
English: If you forget to take a dose, do not take a double dose to make up for a forgotten dose.
Croatian: Ako ste Vi ili bolesnik zaboravili uzeti Epidyolex Ako ste zaboravili uzeti dozu, nemojte uzeti dvostruku dozu kako biste nadoknadili zaboravljenu dozu.
English: The recommended starting dose of cannabidiol is 2.5 mg/kg taken twice daily (5 mg/kg/day) for one week.
Croatian: Preporučena početna doza kanabidiola je 2,5 mg/kg dvaput dnevno (5 mg/kg/dan) tijekom jednog tjedna.
English: The primary endpoint was the percentage change from baseline in drop seizures per 28 days over the treatment period for the cannabidiol group compared to placebo.
Croatian: Primarna mjera ishoda je bila postotna promjena u odnosu na početnu vrijednost astatskih napadaja u 28 dana tijekom razdoblja liječenja za skupinu na kanabidiolu u odnosu na placebo.
English: Adjunctive therapy in patients with Lennox-Gastaut syndrome (LGS) The efficacy of cannabidiol for the adjunctive therapy of seizures associated with Lennox-Gastaut syndrome (LGS) was evaluated in two randomised, double-blind, placebo-controlled, parallel-group studies (GWPCARE3 and GWPCARE4).
Croatian: Dodatna terapija u bolesnika sa Lennox-Gastautovim sindromom (LGS) Učinkovitost kanabidiola za dodatnu terapiju napadaja povezanih sa Lennox-Gastautovim sindromom (LGS) je procijenjena u dva randomizirana, dvostruko slijepa, placebom kontrolirana ispitivanja s paralelnim skupinama (GWPCARE3 i GWPCARE4).